home / stock / mdwd / mdwd news

MDWD News and Press, MediWound Ltd. From 02/18/20

Stock Information
Company Name: MediWound Ltd.
Stock Symbol: MDWD
Market: NASDAQ
Website: mediwound.com
Menu
MDWD MDWD Quote MDWD Short MDWD News MDWD Articles MDWD Message Board
Get MDWD Alerts

News, Short Squeeze, Breakout and More Instantly...
MDWD - MediWound to Report Fourth Quarter & Fiscal 2019 Financial Results and Host a Conference Call and Webcast on February 25, 2020

YAVNE, Israel, Feb. 18, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced that the Company will release its financial results for the ...
MDWD - MediWound Expands its Distribution Agreement with GENFA MEDICA SA to Market NexoBrid in Ukraine and the Baltic States

YAVNE, Israel, Jan. 13, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced the expansion of its agreement with GENFA MEDICA SA, grantin...

MDWD - BARDA to procure NexoBrid for emergency responses

MediWound (NASDAQ: MDWD ) and its commercial partner Vericel (NASDAQ: VCEL ) announces that the U.S. Biomedical Advanced Research and Development Authority (BARDA), has begun procuring NexoBrid for emergency stockpile as part of the U.S. Department of Health and Human Servic...

MDWD - BARDA Initiates the Procurement of NexoBrid for Emergency Response

YAVNE, Israel and CAMBRIDGE, Mass., Jan. 06, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) and its U.S. commercial partner Vericel Corporation (NASDAQ: VCEL) today announced that the U.S. Biomedical Advanced Research and Development Authority (BARDA) within the Assistant Secretary ...
MDWD - MediWound +10% premarket on distribution deal for NexoBrid

MediWound (NASDAQ: MDWD ) is up  10%  premarket on  signing a distribution agreement granting Balance Medical Pty Ltd. the exclusive rights to market and distribute NexoBrid in Australia, New Zealand and Singapore for the treatment of severe burns. More news on: MediWo...

MDWD - MediWound Continues NexoBrid's Global Expansion Through a New Distribution Agreement in Australia, New Zealand and Singapore with Balance Medical

YAVNE, Israel, Jan. 02, 2020 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced the signing of a distribution agreement granting Balance Med...

MDWD - MediWound launches mid-stage study of EscharEx in venous leg ulcers

MediWound ( MDWD -1.2% ) initiates a Phase 2 clinical trial evaluating EscharEx, a topical biologic designed to enzymatically debride (remove dead tissue) chronic wounds, for the treatment of venous leg ulcers. More news on: MediWound Ltd., Healthcare stocks news, Read more ...

MDWD - MediWound Initiates U.S. Phase 2 Adaptive Design Study of EscharEx® for Treatment of Venous Leg Ulcers

YAVNE, Israel, Dec. 03, 2019 (GLOBE NEWSWIRE) -- MediWound Ltd. (the “Company”) (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today announced the initiation of patient trea...

MDWD - MediWound Ltd. (MDWD) CEO Sharon Malka on Q3 2019 Results - Earnings Call Transcript

MediWound Ltd. (MDWD) Q3 2019 Earnings Conference Call November 14, 2019, 08:30 AM ET Company Participants Jeremy Feffer - IR Sharon Malka - CEO Boaz Gur-Lavie - CFO Conference Call Participants Anthony Petrone - Jefferies & Co. Bryan Bergin - Cowen Presentation ...

MDWD - MediWound EPS beats by $0.04, beats on revenue

MediWound (NASDAQ: MDWD ): Q3 GAAP EPS of -$0.11 beats by $0.04 . More news on: MediWound Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...

Previous 10 Next 10